Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human APLP2 ELISA Kit (AC2491)
Cat.#: ASET-1080
Specifications
Description Human APLP2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human APLP2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.76 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 250-4000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1039 Human P2Y2 ELISA Kit (AC2450) Quantitative inquiry ASET-1444 Human SorCS1 ELISA Kit (AC2855) Quantitative inquiry ASET-1857 Human DLL1 ELISA Kit (AC3268) Quantitative inquiry ASET-1436 Rat Oxytocin Receptor ELISA Kit (AC2847) Quantitative inquiry ASET-1454 Horse beta Endorphin ELISA Kit (AC2865) Quantitative inquiry ASET-1783 Mouse DDR2 ELISA Kit (AC3194) Quantitative inquiry ASET-1473 Human NTE ELISA Kit (AC2884) Quantitative inquiry ASET-1171 Human SYT6 ELISA Kit (AC2582) Quantitative inquiry ASET-2358 Human Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC3769) Quantitative inquiry ASET-2309 Human NECL-1 ELISA Kit (AC3720) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket